CYP2D6 GENOTYPING AND THE ASSOCIATION WITH LUNG-CANCER SUSCEPTIBILITY

被引：24

作者：

WOLF, CR

SMITH, CAD

BISHOP, T

FORMAN, D

GOUGH, AC

SPURR, NK

机构：

[1] ST JAMES UNIV HOSP, IMPERIAL CANC RES FUND, GENET EPIDEMIOL LAB, LEEDS LS9 7TF, W YORKSHIRE, ENGLAND

[2] CLARE HALL LABS, IMPERIAL CANC RES FUND, HUMAN GENET RESOURCES LAB, POTTERS BAR EN6 3LR, HERTS, ENGLAND

[3] RADCLIFFE INFIRM, IMPERIAL CANC RES FUND, CANC EPIDEMIOL UNIT, OXFORD OX2 6HE, ENGLAND

来源：

PHARMACOGENETICS | 1994年 / 4卷 / 02期

关键词：

D O I：

10.1097/00008571-199404000-00008

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：104 / 106

页数：3

共 20 条

[1] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].

AYESH, R ;

IDLE, JR ;

RITCHIE, JC ;

CROTHERS, MJ ;

HETZEL, MR .

NATURE, 1984, 312 (5990) :169-170

[2] DEBRISOQUINE OXIDATION PHENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER [J].

BOOBIS, AR ;

DAVIES, DS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (04) :653-656

[3] THE RATIONALE FOR CASE-CONTROL METHODOLOGY IN EPIDEMIOLOGIC STUDIES OF CANCER RISK - RESPONSE [J].

CAPORASO, N ;

IDLE, JR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (01) :149-150

[4]

CAPORASO N, 1989, CANCER RES, V49, P3675

[5] LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE [J].

CAPORASO, NE ;

TUCKER, MA ;

HOOVER, RN ;

HAYES, RB ;

PICKLE, LW ;

ISSAQ, HJ ;

MUSCHIK, GM ;

GREENGALLO, L ;

BUIVYS, D ;

AISNER, S ;

RESAU, JH ;

TRUMP, BF ;

TOLLERUD, D ;

WESTON, A ;

HARRIS, CC .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15) :1264-1272

[6] GENETIC AND METABOLIC CRITERIA FOR THE ASSIGNMENT OF DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P4502D6) PHENOTYPES [J].

DALY, AK ;

ARMSTRONG, M ;

MONKMAN, SC ;

IDLE, ME ;

IDLE, JR .

PHARMACOGENETICS, 1991, 1 (01) :33-41

[7] LACK OF A RELATIONSHIP BETWEEN THE POLYMORPHISM OF DEBRISOQUINE OXIDATION AND LUNG-CANCER [J].

DUCHE, JC ;

JOANNE, C ;

BARRE, J ;

DECREMOUX, H ;

DALPHIN, JC ;

DEPIERRE, A ;

BROCHARD, P ;

TILLEMENT, JP ;

BECHTEL, P .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (05) :533-536

[8] IDENTIFICATION OF THE PRIMARY GENE DEFECT AT THE CYTOCHROME-P450 CYP2D LOCUS [J].

GOUGH, AC ;

MILES, JS ;

SPURR, NK ;

MOSS, JE ;

GAEDIGK, A ;

EICHELBAUM, M ;

WOLF, CR .

NATURE, 1990, 347 (6295) :773-776

[9]

HANIOKA N, 1990, AM J HUM GENET, V47, P994

[10] GENOTYPING OF POOR METABOLIZERS OF DEBRISOQUINE BY ALLELE-SPECIFIC PCR AMPLIFICATION [J].

HEIM, M ;

MEYER, UA .

LANCET, 1990, 336 (8714) :529-532

← 1 2 →